Mary Stracke

Title: Mary Stracke: Innovator in Cancer Diagnosis and Therapy

Introduction

Mary Stracke is a notable inventor based in Rockville, MD (US). She has made significant contributions to the field of cancer research, particularly through her work on autotaxin, a motility stimulating protein. With a total of 5 patents to her name, Stracke's innovations are paving the way for advancements in cancer diagnosis and therapy.

Latest Patents

One of her latest patents focuses on autotaxin, detailing a DNA segment encoding this protein. The invention encompasses recombinant DNA molecules containing the DNA segment, as well as cells that harbor the recombinant DNA molecule. Additionally, it outlines a method for producing autotaxin, the development of antibodies to autotaxin, and the identification of functional domains within the protein. This work is crucial for enhancing cancer diagnosis and therapeutic strategies.

Career Highlights

Throughout her career, Mary Stracke has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the United States of America, as represented by the Secretary, Department of Health and Human Services. Her contributions have been instrumental in advancing medical research and innovation.

Collaborations

Mary has collaborated with notable professionals in her field, including Lance A. Liotta and Elliott Schiffmann. These partnerships have further enriched her research and development efforts.

Conclusion

Mary Stracke's work exemplifies the impact of innovation in the medical field, particularly in cancer research. Her patents and collaborations highlight her commitment to improving health outcomes through scientific advancements.